Home Data Calendar Blog

XNCR

Tables

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Common Stock Value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.57 0.57 0.57 0.56 0.56 0.56 0.56 0.47 0.47 0.47 0.47

Earnings Per Share Basic -0.55 -0.57 0.40 1.26 -0.69 0.90 -0.04 -0.24 -0.22 -0.61 -0.14 -0.47 -0.18 -0.28 1.42 -0.32 0.06 -0.25 -0.33 -0.15 -0.31

Earnings Per Share Diluted -0.55 -0.57 0.39 1.21 -0.69 0.87 -0.04 -0.24 -0.22 -0.61 -0.14 -0.47 -0.18 -0.28 1.38 -0.32 0.05 -0.25 -0.33 -0.15 -0.31

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Revenue From Contract With Customer Excluding Assessed Tax 0.03 0.03 0.09 0.15 0.02 0.07 0.03 0.04 0.04 13.09 32.38 3.52 21.76 19.48 111.94 11.56 29.04 30.15 0.00 12.50 3.50

Revenues 0.03 0.03 0.09 0.15 0.02 0.07 0.03 0.04 0.04 13.09 32.38 3.52 21.76 19.48 111.94 11.56 29.04 30.15 0.00 12.50 3.50

Operating Expenses 0.07 0.06 0.06 0.06 0.06 0.06 0.05 0.06 0.05 50.69 41.16 34.09 36.04 39.06 33.70 32.65 28.39 24.82 23.58 21.01 19.86

Research And Development Expense 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.05 0.04 43.46 33.94 27.34 29.77 33.30 28.18 27.13 20.95 20.40 19.41 16.92 15.05

General And Administrative Expense 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 7.23 7.22 6.75 6.27 5.76 5.51 5.52 7.43 4.43 4.17 4.09 4.81

Operating Income Loss -0.04 -0.03 0.03 0.09 -0.04 0.01 -0.02 -0.01 -0.02 -37.60 -8.78 -30.57 -14.28 -19.57 78.24 -21.08 0.65 -13.88 -16.49 -7.67 -15.52

Interest Income Expense Net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.09 3.04 3.42 3.70 3.62 2.89 2.81 2.64 1.05 1.04 NA NA

Interest Paid Net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00

Income Tax Expense Benefit 0.00 NA NA NA NA NA NA NA NA NA NA -0.29 -0.35 0.05 0.90 NA NA -1.09 0.17 0.28 0.17

Profit Loss -0.03 -0.03 0.02 0.07 -0.04 0.05 -0.00 -0.01 43.04 -35.02 -8.07 -26.91 -10.22 -16.03 80.05 -18.20 3.15 -11.84 -15.56 -6.04 -15.47

Net Income Loss -0.03 -0.03 0.02 0.07 -0.04 0.05 -0.00 -0.01 -0.01 -35.02 -8.07 -26.91 -10.22 -16.03 80.05 -18.20 3.15 -11.84 -15.56 -6.88 -14.63

Comprehensive Income Net Of Tax -0.03 -0.04 0.02 0.07 -0.04 0.05 -0.00 -0.01 -0.01 -34.59 -8.18 -27.19 -10.42 -14.75 81.36 -16.83 2.82 -12.55 -15.42 -6.93 -14.39

Net Income Loss Available To Common Stockholders Basic -0.03 -0.03 0.02 0.07 -0.04 0.05 -0.00 -0.01 -0.01 -35.02 -8.07 -26.91 -10.22 -16.03 80.05 -18.20 3.15 -3.07 -22.65 -7.72 -15.47

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Assets 0.84 0.85 0.86 0.84 0.70 0.70 0.69 0.70 0.65 644.72 666.96 670.25 686.24 684.75 697.00 576.73 585.59 390.10 398.25 416.16 418.30

Liabilities 0.11 0.11 0.09 0.10 0.08 0.05 0.11 0.13 0.08 74.08 73.96 77.05 76.01 76.66 87.44 55.05 53.31 108.06 107.72 114.80 114.56

Liabilities And Stockholders Equity 0.84 0.85 0.86 0.84 0.70 0.70 0.69 0.70 0.65 644.72 666.96 670.25 686.24 684.75 697.00 576.73 585.59 390.10 398.25 416.16 418.30

Stockholders Equity 0.72 0.74 0.76 0.73 0.62 0.65 0.58 0.57 0.57 570.64 593.00 593.20 610.24 608.09 609.57 521.68 532.27 282.05 290.54 301.37 303.75

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Assets Current 0.67 0.59 0.51 0.42 0.33 0.48 0.59 0.64 0.57 603.39 588.11 558.40 573.76 527.01 488.67 315.73 286.92 230.88 217.81 210.98 166.09

Cash And Cash Equivalents At Carrying Value 0.05 0.05 0.08 0.14 0.04 0.12 0.18 0.16 0.06 109.53 73.81 50.31 51.19 32.56 21.86 26.25 35.00 16.53 13.63 11.22 13.56

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 0.05 0.05 0.08 0.14 0.04 0.12 0.18 0.16 0.06 109.53 73.81 50.31 51.19 32.56 21.86 26.25 35.00 16.53 13.63 11.22 NA

Accounts Receivable Net Current 0.04 0.05 0.09 0.07 0.02 0.01 0.01 0.01 0.01 8.93 6.83 21.57 4.35 10.13 137.68 10.19 2.46 1.14 0.83 14.88 6.94

Prepaid Expense And Other Assets Current 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 7.40 6.48 6.55 7.53 11.31 9.43 10.38 12.10 5.61 7.03 7.62 4.37

Equity Securities Fv Ni 0.03 0.03 0.03 0.04 0.05 0.05 0.01 0.01 0.01 2.61 2.25 NA NA NA NA NA NA NA NA NA NA

Available For Sale Securities Debt Securities 0.56 0.58 0.52 0.45 0.48 0.44 0.39 0.44 0.52 475.26 536.07 551.00 569.29 593.58 490.97 504.22 512.83 NA 359.37 367.51 379.09

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Property Plant And Equipment Net 0.05 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.02 16.24 16.80 15.80 13.87 12.13 11.46 11.81 9.69 7.09 6.08 3.86 3.36

Intangible Assets Net Excluding Goodwill 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 15.16 14.64 14.42 14.03 13.52 12.74 11.97 11.68 11.15 11.04 10.87 10.89

Other Assets Noncurrent 0.00 0.00 0.00 0.00 0.03 0.00 0.01 0.00 0.01 8.79 9.19 0.31 10.19 10.73 11.27 0.31 0.31 0.27 0.27 0.21 0.10

Equity Securities Fv Ni 0.03 0.03 0.03 0.04 0.05 0.05 0.01 0.01 0.01 2.61 2.25 NA NA NA NA NA NA NA NA NA NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Liabilities Current 0.09 0.08 0.06 0.07 0.04 0.05 0.10 0.12 0.07 66.45 65.92 66.56 64.31 63.71 73.32 53.85 52.03 101.34 100.33 107.43 106.88

Accounts Payable Current 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 10.51 10.31 10.19 8.30 8.99 5.49 3.80 5.98 6.87 6.60 7.38 4.28

Taxes Payable Current 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0.16 NA 0.46 0.17

Accrued Liabilities Current 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.02 0.01 9.16 7.29 8.99 7.83 6.23 5.71 9.66 5.67 5.48 4.64 3.98 6.50

Contract With Customer Liability Current 0.04 0.04 0.04 0.04 0.01 0.02 0.08 0.09 0.04 44.69 46.18 45.20 45.58 45.48 59.24 40.08 40.08 60.12 NA NA NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Operating Lease Liability Noncurrent 0.02 0.03 0.03 0.03 0.03 0.00 0.01 0.01 0.01 7.63 8.04 8.56 9.08 9.65 10.22 NA NA NA NA NA NA

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Stockholders Equity 0.72 0.74 0.76 0.73 0.62 0.65 0.58 0.57 0.57 570.64 593.00 593.20 610.24 608.09 609.57 521.68 532.27 282.05 290.54 301.37 303.75

Common Stock Value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.57 0.57 0.57 0.56 0.56 0.56 0.56 0.47 0.47 0.47 0.47

Additional Paid In Capital 1.06 1.04 1.03 1.02 0.97 0.96 0.95 0.94 0.92 908.08 895.86 887.87 877.72 865.16 851.89 845.37 839.13 570.67 566.61 562.02 557.47

Retained Earnings Accumulated Deficit -0.33 -0.29 -0.26 -0.28 -0.36 -0.32 -0.37 -0.37 -0.35 -339.49 -304.48 -296.40 -269.49 -259.27 -243.23 -323.28 -305.08 -287.29 -275.44 -259.88 -253.00

Accumulated Other Comprehensive Income Loss Net Of Tax -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 0.00 0.00 0.00 1.48 1.06 1.16 1.44 1.63 0.34 -0.97 -2.34 -1.81 -1.10 -1.24 -1.20

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.01 0.01 0.01 NA 0.01 0.01 0.01 NA 0.01 8.23 6.51 NA 9.51 9.30 5.86 5.08 6.12 3.44 3.60 3.45 3.16

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Net Cash Provided By Used In Operating Activities -0.00 0.04 0.01 0.06 -0.04 -0.01 -0.03 0.02 18.20 -27.68 9.46 -19.58 -6.48 109.16 -18.73 -16.78 -10.31 -6.67 -3.51 -12.96 -10.55

Net Cash Provided By Used In Investing Activities 0.00 -0.08 -0.07 0.01 -0.04 -0.05 0.04 0.08 -71.95 59.41 12.56 15.73 22.06 -102.43 13.67 6.87 5.86 8.94 4.93 9.53 8.55

Net Cash Provided By Used In Financing Activities 0.00 0.00 0.00 0.03 0.00 0.00 0.01 0.01 -5.46 4.00 1.47 2.97 3.05 3.97 0.67 1.17 4.15 0.62 0.99 1.10 1.03

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Net Cash Provided By Used In Operating Activities -0.00 0.04 0.01 0.06 -0.04 -0.01 -0.03 0.02 18.20 -27.68 9.46 -19.58 -6.48 109.16 -18.73 -16.78 -10.31 -6.67 -3.51 -12.96 -10.55

Net Income Loss -0.03 -0.03 0.02 0.07 -0.04 0.05 -0.00 -0.01 -0.01 -35.02 -8.07 -26.91 -10.22 -16.03 80.05 -18.20 3.15 -11.84 -15.56 -6.88 -14.63

Profit Loss -0.03 -0.03 0.02 0.07 -0.04 0.05 -0.00 -0.01 43.04 -35.02 -8.07 -26.91 -10.22 -16.03 80.05 -18.20 3.15 -11.84 -15.56 -6.04 -15.47

Depreciation Depletion And Amortization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.81 1.44 1.37 1.23 1.07 1.01 1.00 0.88 0.82 0.61 0.56 0.45 0.41

Increase Decrease In Accounts Payable -0.00 0.00 -0.00 0.00 0.00 -0.00 -0.00 -0.00 -0.32 0.20 0.12 1.88 -0.69 3.51 1.69 -2.19 1.07 0.27 -0.78 3.10 0.40

Share Based Compensation 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 6.51 7.18 9.51 9.30 5.86 5.08 6.12 3.44 3.60 3.45 3.16

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Net Cash Provided By Used In Investing Activities 0.00 -0.08 -0.07 0.01 -0.04 -0.05 0.04 0.08 -71.95 59.41 12.56 15.73 22.06 -102.43 13.67 6.87 5.86 8.94 4.93 9.53 8.55

Payments To Acquire Property Plant And Equipment 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 -2.69 0.62 2.07 2.91 2.58 1.45 0.41 2.79 1.01 1.48 2.58 0.76 0.49

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Net Cash Provided By Used In Financing Activities 0.00 0.00 0.00 0.03 0.00 0.00 0.01 0.01 -5.46 4.00 1.47 2.97 3.05 3.97 0.67 1.17 4.15 0.62 0.99 1.10 1.03

2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-12-31 2017-09-30 2017-06-30 2017-03-31

Revenues 0.03 0.03 0.09 0.15 0.02 0.07 0.03 0.04 0.04 13.09 32.38 3.52 21.76 19.48 111.94 11.56 29.04 30.15 0.00 12.50 3.50

Alexion Pharmaceuticals Inc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80 3.30 2.50 5.40 5.10 NA 11.00 9.00 NA NA NA NA

Astellas 0.00 0.00 0.00 NA NA NA NA 0.00 -0.90 0.70 0.30 0.20 0.00 13.80 NA NA NA NA NA NA NA

Janssen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Morpho Sys 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.50 NA NA NA NA NA NA NA NA NA NA

Vir Biotechnology 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 -0.30 0.30 NA -0.70 0.70 NA NA NA NA NA NA NA NA

Royalty 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80 3.30 2.50 1.40 1.10 NA NA NA NA NA NA NA

Collaboration 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.50 1.00 1.10 0.60 14.40 0.30 0.10 20.00 NA NA NA NA

Milestone 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 12.50 -0.10 19.30 4.00 NA 11.50 9.00 NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 0.03 0.03 0.09 0.15 0.02 0.07 0.03 0.04 0.04 13.09 32.38 3.52 21.76 19.48 111.94 11.56 29.04 30.15 0.00 12.50 3.50

Alexion Pharmaceuticals Inc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80 3.30 2.50 5.40 5.10 NA 11.00 9.00 NA NA NA NA

Astellas 0.00 0.00 0.00 NA NA NA NA 0.00 -0.90 0.70 0.30 0.20 0.00 13.80 NA NA NA NA NA NA NA

Janssen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Morpho Sys 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.50 NA NA NA NA NA NA NA NA NA NA

Vir Biotechnology 0.00 0.00 0.00 0.00 0.00 0.00 NA 0.00 -0.30 0.30 NA -0.70 0.70 NA NA NA NA NA NA NA NA

Royalty 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80 3.30 2.50 1.40 1.10 NA NA NA NA NA NA NA

Collaboration 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.50 1.00 1.10 0.60 14.40 0.30 0.10 20.00 NA NA NA NA

Milestone 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 12.50 -0.10 19.30 4.00 NA 11.50 9.00 NA NA NA NA

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Other Nonoperating Income Expense

Balance Sheet

Intangible Assets Net Excluding Goodwill

Assets

Intangible Assets Net Excluding Goodwill

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Other Assets Noncurrent

Liabilities

Operating Lease Liability

Current Liabilities

Taxes Payable Current

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Income Loss

NetCashProvidedByUsedInOperatingActivities

Net Income Loss

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

OperatingLeaseLiability

Operating Lease Liability Current

NonoperatingIncomeExpense

Other Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:Revenues
us-gaap:CounterpartyName
(None,)

Revenuesus-gaap: Counterparty Name

us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:StatementEquityComponents
(None,)

Comprehensive Income Net Of Taxus-gaap: Statement Equity Components

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:InvestmentType
(None,)

Cash And Cash Equivalents At Carrying Valueus-gaap: Investment Type

us-gaap:EquitySecuritiesFvNi
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
(None, 'us-gaap:CommonStock')

Equity Securities Fv Nius-gaap: Counterparty Name, us-gaap: Statement Class Of Stock

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)

Available For Sale Securities Debt Securitiesus-gaap: Investment Type

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType
('us-gaap:FairValueInputsLevel2', None)

Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Investment Type

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)

Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)

Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument

us-gaap:EquitySecuritiesFvNi
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
(None, 'us-gaap:CommonStock')

Equity Securities Fv Nius-gaap: Counterparty Name, us-gaap: Statement Class Of Stock

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:ShareBasedCompensation
us-gaap:IncomeStatementLocation
(None,)

Share Based Compensationus-gaap: Income Statement Location

us-gaap:ShareBasedCompensation
us-gaap:AwardType
(None,)

Share Based Compensationus-gaap: Award Type

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:Revenues
us-gaap:CounterpartyName
(None,)

Revenuesus-gaap: Counterparty Name

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name